National Asset Management, Inc. Horizon Therapeutics Public LTD CO Transaction History

National Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $515,542 - $573,409	-5,978 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $81,024 - $107,701	1,128 Added 23.26%	5,978 $552,000
Q4 2020 Feb 04, 2021	SELL	$67.0 - $84.39 $227,532 - $286,588	-3,396 Reduced 41.18%	4,850 $356,000
Q3 2020 Nov 09, 2020	BUY	$55.23 - $79.93 $239,863 - $347,135	4,343 Added 111.27%	8,246 $637,000
Q2 2020 Jul 31, 2020	BUY	$30.2 - $56.98 $117,870 - $222,392	3,903 New	3,903 $218,000
Q1 2020 May 06, 2020	SELL	$24.87 - $38.56 $175,408 - $271,963	-7,053 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$25.43 - $36.67 $179,357 - $258,633	7,053 New	7,053 $256,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.